Aldesulfone sodium: Difference between revisions
Appearance
Content deleted Content added
Script assisted update of identifiers from ChemSpider, CommonChemistry and FDA for the Chem/Drugbox validation project - Updated: {{cascite}} StdInChI StdInChIKey. |
Updating {{drugbox}} (no changed fields - added verified revid - updated 'StdInChI_Ref', 'StdInChIKey_Ref') per Chem/Drugbox validation (report errors |
||
Line 1: | Line 1: | ||
{{drugbox |
{{drugbox |
||
| verifiedrevid = |
| verifiedrevid = 401594884 |
||
| IUPAC_name = [4-[4-(sulfinomethylamino) phenyl] sulfonylphenyl] aminomethanesulfinic acid |
| IUPAC_name = [4-[4-(sulfinomethylamino) phenyl] sulfonylphenyl] aminomethanesulfinic acid |
||
| image = Aldesulfone.svg |
| image = Aldesulfone.svg |
||
Line 10: | Line 10: | ||
| InChIKey = AZBNFLZFSZDPQF-NUQVWONBAG |
| InChIKey = AZBNFLZFSZDPQF-NUQVWONBAG |
||
| PubChem = 8954 |
| PubChem = 8954 |
||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
|||
| StdInChI = 1S/C14H16N2O6S3.2Na/c17-23(18)9-15-11-1-5-13(6-2-11)25(21,22)14-7-3-12(4-8-14)16-10-24(19)20;;/h1-8,15-16H,9-10H2,(H,17,18)(H,19,20);;/q;2*+1/p-2 |
| StdInChI = 1S/C14H16N2O6S3.2Na/c17-23(18)9-15-11-1-5-13(6-2-11)25(21,22)14-7-3-12(4-8-14)16-10-24(19)20;;/h1-8,15-16H,9-10H2,(H,17,18)(H,19,20);;/q;2*+1/p-2 |
||
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
|||
| StdInChIKey = AZBNFLZFSZDPQF-UHFFFAOYSA-L |
| StdInChIKey = AZBNFLZFSZDPQF-UHFFFAOYSA-L |
||
| CAS_number = 144-75-2 |
| CAS_number = 144-75-2 |
Revision as of 09:47, 10 December 2010
Clinical data | |
---|---|
Routes of administration | Oral |
ATC code | |
Pharmacokinetic data | |
Protein binding | 69% |
Metabolism | Hepatic |
Elimination half-life | 3 to 8 hours |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C14H16N2O6S3 |
Molar mass | 404.485 g/mol g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Aldesulfone sodium (or sulfoxone) is an antibiotic used in the treatment of leprosy.
Sulfoxone sodium was introduced in Japan in 1948.[1]
References
- ^ PMID 12412600